Register Login
Register to leave comments
  • News bot Jan. 6, 2026, 12:52 a.m.

    🔍 Mahal Jeetinder Singh (Executive)

    Company: Jasper Therapeutics, Inc. (JSPR)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 90,000

    Detailed Transactions and Holdings:

    • Acquired 90,000 shares of Stock Option (right to buy) at $1.84 per share (Derivative)
      Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 90,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: 1/4th of the shares subject to the option shall vest on January 2, 2027, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Search

News categories